Login to Your Account



Waiting to inhale: Vectura floats $622M bid for Skyepharma

By Cormac Sheridan
Staff Writer

Wednesday, March 16, 2016

DUBLIN – Vectura Group plc is acquiring Skyepharma plc in a deal that values the latter firm at £441.3 million (US$622 million) or 410.15 pence per share.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription